Formed in 2016, Anticancer Bioscience is a private company, registered in China. It has been formed to commercialize innovations emerging from China’s prestigious J. Michael Bishop Institute of Cancer Research.

We are ambitious and intend to make rapid progress. Although well financed, we are open to initiating discussions with specialist life science investors, and/or the venture arms of pharma companies for future financings.

See our most recent financing news.

If you are interested in investing in Anticancer Bioscience please contact us.